The Growing Connection Between AI and Cancer Research
Analysts project that the global market size of AI in oncology could grow from $891 million in 2022 to $10.7 billion in 2032. Tempus, the owner of the world’s largest AI-driven clinical data library, is positioned to capitalise on this opportunity. Using AI to gather insights from over 6 million patient records, Tempus helps healthcare professionals better diagnose and treat cancer. Not only that